Work

A phase I study of erlotinib in combination with chemoradiation (CRT) for unresectable, locally advanced non-small cell lung cancer (NSCLC)

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.7113

Authors: P. C. Hoffman, A. M. Mauer, D. C. Haraf, E. P. Lester, L. L. Szeto, E. E. Vokes

Institution: University of Chicago

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589893659

Cites:

Cited by: 10

Related to: 10